Fupro

Nimish Mehra and Cyril Joe Baby are Season 4's most college-project-to-life-changing-company founders. What began as an academic exercise in engineering innovation evolved into a company that has impacted 15,000 lives through affordable, high-tech prosthetic limbs that most Indians could never previously access. The founding mission was crystallised by a pivotal encounter: national-level mountaineer Anshul suffered an accident that threatened to end his climbing career. Fupro's prosthetic leg restored his mobility so effectively that he returned to mountain climbing, a demonstration so powerful that the founders brought Anshul to the Shark Tank stage to show the Sharks (and millions of viewers) what their prosthetics could achieve. Watching a mountaineer scale heights on a Fupro prosthetic leg was the pitch's most emotionally overwhelming moment.

Fupro manufactures high-tech prosthetic limbs using proprietary materials with superior elasticity specifically engineered to replicate natural human walking and running biomechanics. Unlike conventional prosthetics that use rigid materials (limiting natural movement and potentially restricting blood flow), Fupro's material science innovation creates prosthetics that flex, absorb impact, and respond to terrain changes the way a natural limb would. The 20-product portfolio covers diverse amputation types and mobility needs: from basic walking prosthetics for elderly diabetic amputees to high-performance athletic prosthetics for mountaineers and sportspersons. All products are designed and manufactured entirely in-house, giving Fupro complete quality control from material selection through final assembly. The 5 patented designs protect the company's most commercially distinctive innovations from replication.

Amount Asked: ₹60 lakhs Equity Offered: 1% Implied Pre-Money Valuation: ₹60 crore

Nimish and Cyril walked into Season 4 Episode 12 with the most physically and emotionally transformative product demonstration of the entire season. National-level mountaineer Anshul appeared on stage wearing a Fupro prosthetic leg, demonstrating that the prosthetic enabled not just walking but athletic performance at competitive levels. The visual of a mountaineer climbing with a prosthetic leg silenced the studio. The founders explained their material science innovation: the superior elasticity designed to replicate natural biomechanics, the 5 patented designs, and the 20-product portfolio covering diverse amputation needs. The 15,000 lives impacted statistic converted technical specifications into human stories. However, the pitch's most dramatic moment was not the product but the cap table negotiation.

Kunal Shah (guest Shark) made the most financially aggressive and most ethically controversial offer: ₹2 crore at ₹20 crore valuation, conditional on restructuring the cap table to reduce Ashmeet Kaur's 40% to 25% and redistributing the 15% to Nimish and Cyril. Anupam Mittal shared a deeply personal story about a cousin who faced prosthetic challenges, demonstrating genuine emotional connection to the problem. Ritesh Agarwal joined the three-Shark coalition, seeing the distributed deployment opportunity: Fupro's prosthetics could be deployed through hospitals, rehabilitation centres, and government disability programmes across India using the same distributed operations methodology that OYO used for hotels. Namita Thapar joined bringing Emcure's healthcare institutional network, clinical validation expertise, and pharmaceutical distribution channels, the most directly applicable strategic capabilities for a medical devices company. Aman Gupta joined bringing boAt's manufacturing scaling expertise, consumer product marketing methodology, and D2C distribution capability for Fupro's potential consumer-facing accessories and care products.

Season 4 Episode 12's most ethically tested negotiation. Founders asked ₹60L for 1% (₹60 crore). Kunal offered ₹2 crore at ₹20 crore with cap table restructuring condition (reduce Ashmeet from 40% to 25%). Founders declined: "That would be unethical." Anupam exited on scalability grounds. Ritesh, Namita, and Aman jointly offered ₹60L for 5%. Founders negotiated down to 4%. Final deal: ₹60 lakhs for 4% equity from three Sharks at ₹15 crore valuation. The founders chose a ₹60 lakh clean deal over a ₹2 crore conditional deal because protecting a co-founder's equity was more important than accepting capital that came with ethically uncomfortable conditions.

Nimish Mehra and Cyril Joe Baby accepted the three-Shark deal from Ritesh Agarwal, Namita Thapar, and Aman Gupta at ₹60 lakhs for 4% equity, valuing Fupro at ₹15 crore. The deal brought distributed healthcare deployment (Ritesh), pharmaceutical institutional network and clinical validation (Namita), and consumer hardware manufacturing scaling (Aman) into India's most innovative affordable prosthetics company. The founders' decision to reject Kunal's ₹2 crore for the sake of co-founder ethics, and then accept a smaller deal with integrity intact, is Season 4's most morally defining negotiation moment.

Fupro continues its mission to make high-tech prosthetics accessible to every Indian amputee. The company's vision extends beyond the current 20-product portfolio: plans include expanding into solutions for vision, hearing, and other healthcare needs, utilising Machine Learning and Artificial Intelligence for enhanced prosthetic designs, and aggressively growing in the Indian prosthetic market. The three-Shark combination provides the most strategically complete support ecosystem for a medtech company: Namita's Emcure pharmaceutical channels for institutional healthcare distribution, Ritesh's OYO methodology for distributed deployment across hospitals and rehabilitation centres, and Aman's boAt manufacturing scaling for efficient production of prosthetic components.